Luminex;kliniken Der Stadt Köln Institute Of Pathology And Institute For Hygiene

AUSTIN, Texas and KOLN, Germany, June 8, 2011 - - New CE Marked xTAG(R) Gastrointestinal Pathogen Panel (GPP) Used to Triage Patients at German Kliniken der Stadt Koln Luminex Corporation (NASDAQ: LMNX) and the Kliniken der Stadt Koln, Institute of Pathology and Institute for Hygiene today announced that Luminex's newly released xTAG(R) Gastrointestinal Pathogen Panel (GPP) is being used successfully as a first-line screen for patients at Kliniken der Stadt Koln suspected of having an E.